Search

everythinglearnresearchcommunity

for

Search:↓

Research 10 of 1000+

1. Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer Breast Cancer Research and Treatment · 2016 · 59 citations
2. Selective Androgen Receptor Modulators (SARMs) Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial:Mesenchymal Stem Cell Signaling PloS one · 2014 · 56 citations
3. Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review Pharmacological Reviews · 2022 · 49 citations
4. Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer Current Oncology · 2024 · 6 citations
5. Eribulin Effectiveness and Safety in Metastatic Triple-Negative Breast Cancer: A Narrative Review Borneo Journal of Pharmacy · 2025
6. Safety and effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer in real-world settings: first observations from an interdisciplinary breast cancer centre in Germany Therapeutic Advances in Medical Oncology · 2023 · 34 citations
7. Feasibility and tolerability of eribulin-based chemotherapy versus other chemotherapy regimens for patients with metastatic triple-negative breast cancer: a single-centre retrospective study Frontiers in Cell and Developmental Biology · 2024
8. In-Vitro Anticancer Activity of Chemical Constituents from Etlingera alba Poulsen against Triple Negative Breast Cancer and in silico Approaches towards Matrix metalloproteinase-1 Inhibition Indonesian Journal of Science and Technology · 2022 · 7 citations
9. Ki-67 Levels and Their Association With Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Prospective Observational Study Cureus · 2025 · 2 citations
10. Revising the role of the androgen receptor in breast cancer Journal of Molecular Endocrinology · 2014 · 68 citations

Community

— no results